Fenwick Represents Kinnevik in Leading Livongo's $105 Million Financing

Fenwick & West represented Kinnevik AB, an entrepreneurial, digital industry focused investment company based in Sweden, in its $41 million investment in a $105 million financing in Livongo Health Inc., a leading consumer digital health company empowering people with chronic conditions to live better and healthier lives. General Catalyst co-led the round with participation from additional existing investors including, DFJ, Kleiner Perkins Caufield & Byers, Merck Global Health Innovation Fund, Microsoft Ventures, Sapphire Ventures, Zaffre Investments and 7wire Ventures.

The financing will allow Livongo to support rapid market growth while continuing investment in data science to develop its proprietary platform. More information regarding Kinnevik’s leading a $105 million financing in Livongo can be obtained from the investor’s announcement.

The Fenwick transaction team was led by corporate lawyers Ian Goldstein, Sean Childers and Meredith Evancie.